Cash & equivalents increased 60.9%
Cash & equivalents changed +60.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +60.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed -65.2% from the comparable as-filed period.
Operating income changed -68.2% from the comparable as-filed period.
Operating margin changed -987 basis points from the comparable as-filed period.
Stock-based compensation changed +24.7% from the comparable as-filed period.
Gross margin changed +208 basis points from the comparable as-filed period.
Gross profit changed +8.8% from the comparable as-filed period.
Revenue changed +5.6% from the comparable as-filed period.
Research & development changed -1.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.